Assess Country Situation

  • Review the five WHO recommendations for new drugs (specifically bedaquiline) use here
    • Effective treatment and monitoring
    • Proper patient inclusion
    • Informed consent
    • Adherence to the principles of designing a WHO-recommended MDR-TB regimen
    • Active drug safety surveillance measures and management of adverse events
  • Assess country situation based on the above WHO recommendations
  • Identify gaps in country capacity in infrastructure; appropriate clinical, laboratory, and diagnostic capacity, active surveillance, staff skills, M&E systems, and appropriate management information system and tools to inform effective decisions

Return to previous page

Leave a Reply

Your email address will not be published. Required fields are marked *